Vaccination with synthetic long peptides (SLPs) containing a cytotoxic (CD8+) as well as a helper (CD4+) T cell epitope has shown to induce tumor specific T cell responses that were able to control or even regress tumor outgrowth (1–7). This evidence concerns the gene CD8A and neoplasm.